Sareum Holdings plc (LON:SAR – Get Free Report) shares shot up 11.7% during mid-day trading on Friday . The stock traded as high as GBX 44.75 ($0.57) and last traded at GBX 43 ($0.55). 900,265 shares changed hands during trading, a decline of 10% from the average session volume of 996,774 shares. The stock had previously closed at GBX 38.50 ($0.49).
Sareum Price Performance
The stock has a market cap of £48.04 million, a price-to-earnings ratio of -741.67 and a beta of -1.03. The company’s fifty day moving average price is GBX 34.77 and its 200-day moving average price is GBX 36.86.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Further Reading
- Five stocks we like better than Sareum
- Conference Calls and Individual Investors
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MarketBeat Week in Review – 6/24 – 6/28
- Bank Stocks – Best Bank Stocks to Invest In
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
